Tatsuya Ihara Selected Research

Tatsuya Ihara Research Topics

Disease

6	Nocturia 11/2023 - 01/2019
3	Neoplasms (Cancer) 09/2022 - 12/2021
3	Overactive Urinary Bladder (Overactive Bladder) 03/2022 - 08/2018
2	Lower Urinary Tract Symptoms 01/2018 - 01/2018
1	Chronobiology Disorders (Circadian Rhythm Disorder) 11/2023
1	Prostatic Neoplasms (Prostate Cancer) 09/2022
1	Hyperaldosteronism (Conn Syndrome) 06/2022
1	Cushing Syndrome 06/2022
1	Obesity 06/2022
1	Urge Urinary Incontinence (Urge Incontinence) 03/2022
1	Pulmonary Atelectasis 12/2021
1	Mediastinal Emphysema (Pneumomediastinum) 12/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2021
1	Carcinogenesis 01/2019
1	Small Cell Carcinoma 07/2017
1	Hyponatremia 07/2017
1	Inappropriate ADH Syndrome (SIADH) 07/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2017
1	Infections 02/2017
1	Granuloma 02/2017
1	Epididymitis 02/2017
1	Inflammation (Inflammations) 01/2016
1	Cystitis 01/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	palmidrolIBA 11/2023 - 10/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 02/2020
2	AcidsIBA 01/2022 - 10/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2023
1	Nerve Growth Factor (NGF)IBA 11/2023
1	dimemorfan (AT 17)IBA 10/2023
1	pembrolizumabIBA 09/2022
1	mirabegronIBA 03/2022
1	LipidsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 07/2021
1	Serotonin (5 Hydroxytryptamine)IBA 10/2020
1	hydracrylic acidIBA 10/2020
1	Bile Acids and Salts (Bile Acids)IBA 02/2020
1	4- hydroxy- 5,7,10,13,16,19- docosahexaenoic acidIBA 10/2019
1	Arachidonic Acid (Vitamin F)IBA 10/2019
1	13-hydroxy-9,11-octadecadienoic acidIBA 10/2019
1	anandamide (arachidonylethanolamide)IBA 10/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	Eicosapentaenoic AcidIBA 10/2019
1	9-hydroxyoctadecadienoic acidIBA 10/2019
1	EndocannabinoidsIBA 10/2019
1	lauric acid (dodecanoic acid)IBA 01/2019
1	imidazolelactic acidIBA 01/2019
1	thiazolidine-4-carboxylic acidIBA 01/2019
1	Doxycycline (Periostat)FDA LinkGeneric 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2019
1	Glycerol (Glycerine)FDA LinkGeneric 01/2019
1	CitrullineIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Inosine Monophosphate (IMP)IBA 01/2018
1	AsparagineIBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	ConnexinsIBA 01/2018
1	Vasopressins (Vasopressin)IBA 07/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Connexin 43 (Connexin43)IBA 01/2016
1	AICA ribonucleotide (ZMP)IBA 01/2016

Therapy/Procedure

3	Therapeutics 09/2022 - 02/2017
2	Operative Time 06/2022 - 12/2021
1	Adrenalectomy 06/2022
1	Warm Ischemia 12/2021
1	Nephrectomy 12/2021
1	Radiotherapy 07/2017